Wim van Schooten
Company: TeneoBio
Job title: Chief Scientific Officer
Seminars:
Panel Discussion: Business Development Perspectives on the Fibrosis Space 11:30 am
day: Day Two
Antibody-mediated Inhibition of CD38 for the Treatment of Inflammation and Fibrosis 2:00 pm
day: Day One